Search by Drug Name or NDC
NDC 50268-0183-30 Sodium Citrate and Citric Acid 334; 500 mg/5mL; mg/5mL Details
Sodium Citrate and Citric Acid 334; 500 mg/5mL; mg/5mL
Sodium Citrate and Citric Acid is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is ANHYDROUS CITRIC ACID; SODIUM CITRATE.
Product Information
| NDC | 50268-0183 |
|---|---|
| Product ID | 50268-183_fe0712a4-b475-3f35-e053-6294a90a2ce3 |
| Associated GPIs | |
| GCN Sequence Number | 043912 |
| GCN Sequence Number Description | citric acid/sodium citrate SOLUTION 334-500MG ORAL |
| HIC3 | R1S |
| HIC3 Description | URINARY PH MODIFIERS |
| GCN | 51957 |
| HICL Sequence Number | 003682 |
| HICL Sequence Number Description | CITRIC ACID/SODIUM CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Citrate and Citric Acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SODIUM CITRATE and CITRIC ACID MONOHYDRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 334; 500 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | ANHYDROUS CITRIC ACID; SODIUM CITRATE |
| Labeler Name | AvPAK |
| Pharmaceutical Class | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation F |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50268-0183-30 (50268018330)
| NDC Package Code | 50268-183-30 |
|---|---|
| Billing NDC | 50268018330 |
| Package | 40 CUP, UNIT-DOSE in 1 CARTON (50268-183-30) / 30 mL in 1 CUP, UNIT-DOSE (50268-183-11) |
| Marketing Start Date | 2023-06-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |